Bayer agrees to sell its veterinary drugs business to Elanco for $7.6 billion

Bayer agreed to sell its veterinary drugs business to Elanco for $7.6 billion in cash and stock.
Why it matters: It creates the world’s second-largest animal health company by revenue, behind Zoetis, with a 13% market share. It also will help Bayer cut into …
Read More

Comments

mood_bad
  • No comments yet.
  • Add a comment